Company Filing History:
Years Active: 2003-2004
Title: Innovations by James Crow in Prostaglandin Delivery
Introduction
James Crow is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicine, particularly in the delivery of benzindene prostaglandins. With a total of 2 patents, his work has the potential to improve treatment methods for various medical conditions.
Latest Patents
James Crow's latest patents include a method for delivering benzindene prostaglandins by inhalation. This method discusses the administration of a benzindene prostaglandin known as UT-15, which has shown unexpectedly superior results when delivered by inhalation compared to parenteral administration in sheep with induced pulmonary hypertension. Another patent focuses on treating peripheral vascular disease by administering benzindene prostaglandins through inhalation, reiterating the effectiveness of UT-15 in similar conditions.
Career Highlights
James Crow is currently associated with United Therapeutics Corporation, where he continues to innovate in the field of drug delivery systems. His work is pivotal in advancing therapeutic options for patients suffering from pulmonary hypertension and peripheral vascular diseases.
Collaborations
James has collaborated with notable colleagues, including Gilles Cloutier and Michael Wade, who contribute to the innovative environment at United Therapeutics Corporation.
Conclusion
James Crow's contributions to the field of medicine through his patents on benzindene prostaglandins highlight his role as a significant inventor. His work not only advances medical treatments but also showcases the importance of innovation in healthcare.